
Izvēlieties etiķeti
redzama tieši uz flakona2 laboratorijas ziņojumi
PDF- Pārbaudīts
- Cagrilintide 10mg
- Laboratorija
- Analiza Białek
- Datums
- November 2026
- Rezultāts
- 99% purity (10.89 mg measured)
- Endotoksīni
- 6.05 EU/vial
- Pasūtījuma nr.
- Parole
PDF- Pārbaudīts
- Cagrilintide 5mg
- Laboratorija
- Analiza Białek
- Datums
- August 2026
- Rezultāts
- 99% purity (5.11 mg measured)
- Endotoksīni
- 3.93 EU/vial
- Pasūtījuma nr.
- Parole
Neatkarīgi pārbaudīts, ar paroli pārbaudāms tieši laboratorijā.
Cagrilintide
Amylin
- Laboratorijā pārbaudīts · 99% tīrība
- Sūtām no Vācijas
Pasūtījums
- DHL ar izsekošanu
- Diskrēts iepakojums
4.6 no 5 Trustpilot73 atsauksmes
Meklēts arī kā: Cagrilintid · AM833
Īsumā
Cagrilintide skaitļos
Galvenie rādītāji no mūsu leksikona.
Pilns leksikona ieraksts- Class
- Long-acting amylin analogue
- Frequency
- Once weekly
- Form
- Lyophilised powderreconstituted with BAC water
- Sizes
- 5 to 20 mg3 sizes in the shop
What studies show
All 2 sources in the lexiconZināšanas
Viss par Cagrilintide
Detalizēta informācija drīzumā.
Dozēšana
Ielādē dozēšanas informāciju …
Noderēs
Kas jums vēl būs vajadzīgs
Bakteriostatiskais ūdens tiek automātiski pievienots grozam. Šļirces un salvetes - ar vienu klikšķi.
Insulīna šļirces
10 gab. · 5.50 €
Spirta salvetes
50 gab. · 10 €
Cik daudz ūdens?
Vienības uz šļirces jūsu flakona izmēram.
Atvērt kalkulatoru →Is cagrilintide approved?
No, according to ChEMBL there is no approval (as of 25 October 2026). ClinicalTrials.gov lists 21 phase 3 trials, ten of them completed. Most test the combination with semaglutide. Cagrilintide alone is being tested in phase 3 in the RENEW trials, with the primary endpoint planned for May 2027.
How does cagrilintide differ from GLP-1 compounds such as semaglutide?
The receptor. Cagrilintide binds to amylin and calcitonin receptors, not to the GLP-1 receptor. In rats it acted through specific nerve cells in the brainstem: when a signal there was switched off, the effect of cagrilintide disappeared but that of semaglutide did not. That is why the combination of the two is being studied.
What did the phase 2 trial show?
In the dose-finding trial with 706 participants weight fell by 6.0 to 10.8 percent after 26 weeks depending on the level, by 3.0 percent on placebo. At the highest level, 53 percent lost at least 10 percent according to the registry, on placebo 10 percent.
How long does cagrilintide stay in the body?
The half-life was 159 to 195 hours in a phase 1b study, so about seven days. That fits one dose a week, which is how the trials give it. With impaired kidney or liver function the level after a single dose was not meaningfully different.
What does the combination with semaglutide add?
In REDEFINE 1 weight fell by 20.4 percent on average after 68 weeks, by 3.0 percent on placebo. With type 2 diabetes (REDEFINE 2) it was 13.7 versus 3.4 percent. In a phase 2 trial in type 2 diabetes participants lost 15.6 percent in 32 weeks with the combination, 8.1 with cagrilintide alone and 5.1 percent with semaglutide alone.
Which side effects were seen?
Most often gastrointestinal effects, above all nausea: in the phase 2 trial 20 to 47 percent had it depending on the level, 18 percent on placebo. Constipation, injection site reactions and, at the highest level, more frequent fatigue came on top. The QT interval on the ECG did not lengthen relevantly in a dedicated study.
Which trials are still running?
Eleven phase 3 trials are not finished yet. The largest is REDEFINE 3 on cardiovascular events with 7,101 participants (primary endpoint planned for September 2027). For cagrilintide alone RENEW 1, 2 and 4 are running, plus a trial in children and adolescents until 2030.
Saistītie
Saistītie produkti
Cagrilintide